Swiss All Share Index
17.704,72
PKT
-266,25
PKT
-1,48
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu Swiss All Share Index-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 05.09.12 | Partners Group hold | Vontobel Research | |
| 05.09.12 | DKSH hold | Vontobel Research | |
| 05.09.12 | Holcim hold | Vontobel Research | |
| 05.09.12 | Novartis reduce | Vontobel Research | |
| 05.09.12 | Swiss Re buy | Vontobel Research | |
| 05.09.12 | Richemont neutral | Sarasin Research | |
| 05.09.12 | Richemont buy | Vontobel Research | |
| 04.09.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 04.09.12 | Zurich Insurance hold | Deutsche Bank AG | |
| 04.09.12 | Swiss Life buy | Deutsche Bank AG | |
| 04.09.12 | Swiss Life buy | Nomura | |
| 04.09.12 | Helvetia Baloise reduce | Nomura | |
| 04.09.12 | Richemont hold | Deutsche Bank AG | |
| 04.09.12 | Holcim hold | Vontobel Research | |
| 04.09.12 | Sika hold | Vontobel Research | |
| 04.09.12 | Partners Group hold | Vontobel Research | |
| 04.09.12 | Sika neutral | Sarasin Research | |
| 04.09.12 | Partners Group neutral | Sarasin Research | |
| 04.09.12 | UBS hold | ING | |
| 04.09.12 | UBS hold | ING | |
| 03.09.12 | Swatch (I) overweight | HSBC | |
| 04.09.12 | Richemont neutral | J.P. Morgan Cazenove | |
| 03.09.12 | UBS buy | Deutsche Bank AG | |
| 03.09.12 | Clariant sell | Goldman Sachs Group Inc. | |
| 03.09.12 | Givaudan sell | Goldman Sachs Group Inc. | |
| 03.09.12 | Sulzer buy | Vontobel Research | |
| 03.09.12 | Holcim hold | Vontobel Research | |
| 03.09.12 | Novartis reduce | Vontobel Research | |
| 03.09.12 | Novartis kaufen | Die Actien-Börse | |
| 31.08.12 | Novartis buy | Deutsche Bank AG | |
| 05.09.12 | Nestlé neutral | Goldman Sachs Group Inc. | |
| 31.08.12 | Holcim neutral | Goldman Sachs Group Inc. | |
| 31.08.12 | Holcim sell | Goldman Sachs Group Inc. | |
| 31.08.12 | Holcim neutral | Citigroup Corp. | |
| 31.08.12 | Holcim sell | Citigroup Corp. | |
| 31.08.12 | UBS buy | Citigroup Corp. | |
| 31.08.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 31.08.12 | Novartis buy | Sarasin Research | |
| 31.08.12 | Helvetia Baloise hold | Vontobel Research | |
| 31.08.12 | SHL Telemedicine hold | Vontobel Research |